Connect
MJA
MJA

Expecting the unexpected: intravenous insulin at Sydney’s medically supervised injecting centre

Marianne E Jauncey, Anita P Trevan and Richard P Sulovsky
Med J Aust 2010; 192 (8): . || doi: 10.5694/j.1326-5377.2010.tb03593.x
Published online: 19 April 2010

To the Editor: In April 2009, a registered nurse at the Sydney Medically Supervised Injecting Centre (MSIC) overheard two clients warning others about the effects of injecting from a particular glass vial, believing it had given them a “dirty shot” (bacterially contaminated injection). Seeing an unlabelled, discarded vial containing cloudy fluid, the nurse was concerned that it may have contained insulin, and assessed all four clients who reported injecting from similar vials. Three clients were sweaty, nauseated, and looked unwell, while only two (who had subsequently injected heroin) showed the pin-point pupils and hypoventilation typical of opioid use. Blood glucose levels confirmed likely insulin use, with the lowest reading being 1.5 mmol/L. MSIC staff made sweet drinks available, but one client became unconscious and required intramuscular glucagon and hospital admission. She was subsequently discharged without complications.


  • Sydney Medically Supervised Injecting Centre, Sydney, NSW.


Correspondence: mjauncey@sydneymsic.com

  • 1. Auer RN. Hypoglycemic brain damage. Metab Brain Dis 2004; 19: 169-175.
  • 2. Sydney Medically Supervised Injecting Centre Interim evaluation report no. 1 (May 2005), Interim evaluation report no. 2 (June 2006), Interim evaluation report no. 3 (March 2007) and Evaluation report no. 4 (June 2007). National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW. http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/page/Resources%20and%20Publications (accessed Jun 2009).
  • 3. Kerr T, Montaner J, Wood E. Supervised injecting facilities: time for scale-up? Lancet 2008; 372: 354-355.
  • 4. Maher L, Salmon AM. Supervised injecting facilities: how much evidence is enough? Drug Alcohol Rev 2007; 26: 351-353.
  • 5. Strathdee SA, Pollini R. A 21st century Lazarus: the role of safer injecting sites in harm reduction and recovery. Addiction 2007; 102: 848-849.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.